Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes-Reference-Cited by-同舟云学术

Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes

Published:2022-01 Issue:1 Volume:32 Page:36-42
ISSN:0960-8966
Container-title:Neuromuscular Disorders
language:en
Short-container-title:Neuromuscular Disorders

Author:

Coratti Giorgia,Carmela Pera Maria,Montes Jacqueline,Scoto Mariacristina,Pasternak Amy,Bovis Francesca^ORCID,Sframeli Maria,D'Amico Adele,Pane Marika,Albamonte Emilio,Antonaci Laura,Lia Frongia Anna,Mizzoni Irene,Sansone Valeria A,Russo Massimo^ORCID,Bruno Claudio,Baranello Giovanni,Messina Sonia,Dunaway Young Sally^ORCID,Glanzman Allan M,Duong Tina,de Sanctis Roberto,Stacy Mazzone Elena,Milev Evelin,Rohwer Annemarie^ORCID,Civitello Matthew^ORCID,Darras Basil T,Bertini Enrico^ORCID,Day John,Muntoni Francesco,De Vivo Darryl C.,Finkel Richard S^ORCID,Mercuri Eugenio^ORCID

Publisher

Elsevier BV

Subject

Genetics (clinical),Neurology (clinical),Neurology,Pediatrics, Perinatology and Child Health

Reference20 articles.

1. Spinal muscular atrophy;D'Amico;Orphanet J Rare Dis,2011

2. Chaos in the classification of SMA: a possible resolution;Dubowitz;Neuromuscul Disord,1995

3. Assessing upper limb function in nonambulant SMA patients: development of a new module;Mazzone;Neuromuscul Disord,2011

4. Revised upper limb module for spinal muscular atrophy: development of a new module;Mazzone;Muscle Nerve,2016

5. Reliability of hand-held dynamometry in spinal muscular atrophy;Merlini;Muscle Nerve,2002

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Upper limb function changes over 12 months in untreated SMA II and III individuals: an item-level analysis using the Revised Upper Limb Module;Neuromuscular Disorders;2024-08

2. Effects of nusinersen on motor function in children with spinal muscular atrophy: a retrospective study;Frontiers in Neurology;2024-07-15

3. JEWELFISH: 24-month results from an open-label study in non-treatment-naïve patients with SMA receiving treatment with risdiplam;Journal of Neurology;2024-05-11

4. Disease Trajectories in the Revised Hammersmith Scale in a Cohort of Untreated Patients with Spinal Muscular Atrophy types 2 and 3;Journal of Neuromuscular Diseases;2024-04-30

5. Long-term efficacy and safety of nusinersen in adults with 5q spinal muscular atrophy: a prospective European multinational observational study;The Lancet Regional Health - Europe;2024-04